Get startedLog in
    Picture of Pharmaids Pharmaceuticals logo

    524572 — Pharmaids Pharmaceuticals Income Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapMomentum Trap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Pharmaids Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2021
    March 31st
    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    2025
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSPRESS
    Standards:
    IAS
    IAS
    IAS
    IAS    		—
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue85.539.40151194
    Cost of Revenue
    Gross Profit3.923.68-8.8836.470.4
    Selling / General / Administrative Expenses
    Depreciation and Amortization
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses84.938.199300347
    Operating Profit0.6211.28-99-149-153
    Gain / Loss on Sale of Assets
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes0.8841.4-99.1-156-173
    Provision for Income Taxes
    Net Income After Taxes0.9331.45-75.6-118-135
    Minority Interest
    Net Income Before Extraordinary Items
    Extraordinary Items
    Net Income0.9331.45-75.6-79.7-108
    Adjustments to Net Income
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income0.9331.45-75.6-79.7-108
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS0.090.14-5.86-3.5-3.03